Figure 2 | Scientific Reports

Figure 2

From: Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer

Figure 2

The expression of human IL-12 in multiple cell lines infected with NDV AF2240 and rAF-IL12 (Passages 1, 5 & 10) determined by ELISA assay at 24, 48 and 72 h. (a) DF-1 cells treated with NDV AF2240 and rAF-IL12 (Passages 1, 5 & 10), (b) MCF-7 cells treated with NDV AF2240 and rAF-IL12 (Passages 1, 5 & 10), (c) MDA-MB231 cells treated with NDV AF2240 and rAF-IL12 (Passages 1, 5 & 10), (d) MCF10A cells treated with NDV AF2240 and rAF-IL12 (Passages 1, 5 & 10). The values are expressed as the mean values ± standard deviation of triplicate experiments. The mean values as indicated using different superscript letters were significantly different at p < 0.05 when compared between parental AF2240- and rAF-IL12 (Passages 1, 5 & 10)-treated groups.

Back to article page